Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Free Cash Flow (2020 - 2025)

Celularity has reported Free Cash Flow over the past 6 years, most recently at -$4.2 million for Q3 2025.

  • Quarterly results put Free Cash Flow at -$4.2 million for Q3 2025, down 2223.46% from a year ago — trailing twelve months through Sep 2025 was -$6.6 million (up 49.21% YoY), and the annual figure for FY2024 was -$6.5 million, up 83.67%.
  • Free Cash Flow for Q3 2025 was -$4.2 million at Celularity, down from -$999000.0 in the prior quarter.
  • Over the last five years, Free Cash Flow for CELU hit a ceiling of $1.6 million in Q4 2024 and a floor of -$37.8 million in Q2 2022.
  • Median Free Cash Flow over the past 5 years was -$10.6 million (2023), compared with a mean of -$16.5 million.
  • Biggest five-year swings in Free Cash Flow: tumbled 7462.61% in 2021 and later skyrocketed 131.76% in 2024.
  • Celularity's Free Cash Flow stood at -$36.6 million in 2021, then grew by 7.75% to -$33.8 million in 2022, then soared by 85.44% to -$4.9 million in 2023, then skyrocketed by 131.76% to $1.6 million in 2024, then tumbled by 366.09% to -$4.2 million in 2025.
  • The last three reported values for Free Cash Flow were -$4.2 million (Q3 2025), -$999000.0 (Q2 2025), and -$3.0 million (Q1 2025) per Business Quant data.